Recruited 6 months ago to lead the US vaccine strategy, Belgian-Moroccan Moncef Slaoui resigned Tuesday January 12 at the request of the Biden team. Dr Slaoui will step down in a month, after leading the unprecedented effort of the US government to develop a safe and effective vaccine against Covid-19 before the end of 2020. The Moroccan-American immunologist had previously announced his intention to resign a once two vaccines and two therapies for Covid-19 were on the market, a goal that was achieved last month with the approval by U.S. health officials of Moderna and Pfizer’s vaccines. Although the vaccination campaign has not been as rapid as expected in the United States, the speed of vaccine development, overseen by Dr Slaoui, has exceeded expectations. Two vaccines have been authorized in the United States with 95% effectiveness against the virus in less than a year.
Trending
- Ivory Coast: ST Digital inaugurates a state-of-the-art data center in Grand-Bassam
- UEMOA: new era with BCEAO’s interoperable instant payment system PI-SPI
- Guinea Bissau raises 16.025 billion CFA francs on the UEMOA financial market
- Chad awards Ali Chimmari the Order of “National Knight” in recognition of the “Noor Chad” project
- Sérgio Pimenta takes the helm of the Africa50 Infrastructure Acceleration Fund (Africa50 IAF)
- Tunisia: 5.15% increase in consolidated profit of Ennakl Automobiles group in the first half of 2025
- IVORY COAST: Banque Atlantique launches the Coffee-Cocoa 2025-2026 campaign
- Banks and mobile money finally connected: BCEAO simplifies payments